Girodmedical has raised US$2 million
Girodmedical SAS has raised US$2 million on a first round of financing via Audacia SAS.
Girodmedical offers medical equipment and medical supplies online. These include massage tables, accessories and furniture, diagnostic equipment and accessories, anatomy models and physiology and anatomy books, medical uniforms and hygiene disinfection and protection products and disposable paper supplies. The company also provides surgical equipment, physiotherapy and rehabilitation products and fitness and sporting goods, comfort and well-being products (such as dental hygiene and aesthetic care) and assisted living products (such as big button phones and incontinence products). Girodmedical was incorporated in 2004 and is based in Nantes, France.
Oaklins’ team in France advised the shareholders of Girodmedical SAS on this transaction.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreSaideep Healthcare and Research has raised equity
Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more